Bio-Sustainable Future Enterprises Regulatory News (BSFA)

BSF Enterprise PLC6 March 2025

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OR OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ANY JURISDICTION.

6 March 2025

BSF Enterprise PLC

Publication of Prospectus

BSF Enterprise Plc (LSE: BSFA) (OTCQB: BSFAF) (the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that, further to the placing announced on 4 December 2024 and 27 December 2024 ("Previous Announcements"), the Company has today received approval from the Financial Conduct Authority (the "FCA") of its prospectus (the "Prospectus") relating to the proposed issuance (the "Share Issue") of up to 28,926,352 new ordinary shares ("Ordinary Shares") and has published its Prospectus.

As described in the Previous Announcements, the Company raised approximately £500,000 by way of placing at a price of 2.5 pence per share in December 2024. 20,000,000 Ordinary Shares were admitted to the Official List of the FCA and to trading on the Main Market of the London Stock Exchange on 27 December 2024.

The Share Issue relates primarily to the warrants that were part of the placing in December 2024 (being 2024 Placing Warrants at a price of 5 pence per share) and part of the £2.9 million fundraise in March 2023 (being 2023 Placing Warrants, 2023 Subscription Warrants and 2023 Broker Warrants at a price of 34 pence per share, together "2023 Fundraising Warrants", which have not been exercised).

At the Company's annual general meeting on 5 March 2025, resolutions were passed to approve the allotment of share and disapplication of pre-emption rights in relation to the Share Issue.

An electronic copy of the Prospectus is available for inspection on the Company's website at www.bsfenterprise.com. The Prospectus will also be available for inspection at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Applications will be made to the FCA and the London Stock Exchange for the new Ordinary Shares in connection with the 2023 Fundraising Warrants and the 2024 Placing Warrants (upon exercise of any of them) to be admitted to the Official List of the FCA and to trading on the Main Market of the London Stock Exchange. It is expected that admission of the new Ordinary Shares will become effective within 10 business days of exercise of the warrants and that dealings will commence at that time.

The new Ordinary Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares of the Company and will on issue be free of all claims, liens, charges, encumbrances and equities.

Further announcements will be made in due course, as appropriate.

Terms used in this announcement shall, unless the context otherwise requires, be as defined in the Prospectus published by the Company on 6 March 2025 in relation to the Share Issue.

For further enquiries, please visit www.bsfenterprise.com or contact:

ISIN of the Ordinary Shares is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.